Alembic Ltd Share Price Target 2027,2030,2035,2040

Share of Alembic Ltd is currently trading at around Rs.101/-. Existing as well as Prospective Investors are asking for Alembic Ltd Share Price Target 2027,2030,2035 & 2040. In this article, we will discuss about the business prospects and financial performance of the Company and based on our discussion and analysis will tell you the Alembic Ltd Share Price Target 2027,2030,2035,2040.

Discussion and Analysis of the Business and Financial Position as well as future Business prospects of Alembic Ltd.

Alembic Ltd is a diversified company belonging to the Alembic Group, with a presence in real estate development, pharmaceutical active pharmaceutical ingredients (API), and investments in group companies. Established in 1907, the company has a long operating history and maintains a significant presence in the Indian corporate sector.

Current Business Position

Alembic Ltd’s business operations are primarily driven by its real estate and pharmaceutical API divisions. The real estate business includes residential and commercial property development, leasing and project management activities. The company also manufactures and markets fermentation-based and chemistry-based pharmaceutical APIs.

Real estate remains the company’s largest business segment. During FY 2025-26, its standalone real estate revenue increased to approximately ₹185.35 crore against ₹182.14 crore in FY 2024-25. Meanwhile, revenue from the API business improved considerably to ₹46.59 crore from ₹32.21 crore in the previous financial year, indicating encouraging growth in this segment.

The company’s standalone revenue from operations increased by approximately 8.2% to ₹231.93 crore in FY26. However, standalone net profit declined to ₹124.54 crore from ₹141.95 crore in FY25, reflecting pressure on profitability despite revenue growth. The company also reported consolidated revenue of approximately ₹240 crore and consolidated net profit of ₹317.38 crore in FY26.

Apart from its operating businesses, Alembic Ltd holds strategic investments in group companies, including approximately 28.41% in Alembic Pharmaceuticals and 19.01% in Paushak Ltd. These investments provide an additional source of potential long-term value. The company also operates co-generation and wind power assets.

Future Business Prospects

Alembic Ltd has several opportunities for future growth. The real estate business could benefit from increasing demand for residential and commercial properties, particularly in developing urban markets. Its existing property portfolio and rental income provide opportunities for recurring revenues, while successful execution of new projects could improve business growth and profitability.

The pharmaceutical API business also offers promising prospects. Increasing demand for quality pharmaceutical ingredients, opportunities in domestic and international markets, and the growing importance of reliable API suppliers could support the company’s expansion. Higher capacity utilisation, operational efficiencies and development of new products may further strengthen this segment.

Another important factor is the company’s investment portfolio. Its holdings in Alembic Pharmaceuticals and Paushak could contribute to long-term shareholder value through dividends and potential appreciation in investment value. The company has also maintained a relatively comfortable borrowing position, with consolidated borrowings declining to approximately ₹11 crore in March 2026 and becoming negligible by September 2026.

Key Risks and Outlook

Despite its growth opportunities, investors should monitor the company’s dependence on real estate, fluctuations in property demand, project execution risks and competition in the pharmaceutical API industry. The September 2026 quarterly results also showed a significant year-on-year decline in consolidated sales, making sustained revenue growth an important factor to watch. Furthermore, consolidated profitability is influenced by other income and investment-related earnings, not just operating performance.

Overall, Alembic Ltd has a diversified business structure, valuable group investments and relatively low debt. Its real estate operations, pharmaceutical API business and strategic investments provide multiple potential growth drivers. However, improvement in operating profitability, consistent revenue growth and better returns on capital will be important for creating sustainable shareholder value over the long term. Investors should evaluate the company’s operating performance and valuation before making investment decisions.

Share Price Targets:

Alembic Ltd Share Price Target 2027:

Based on the above discussion and analysis, the share price of Alembic Ltd is likely to touch the level of around Rs.110-120 in 2027

Alembic Ltd Share Price Target 2030:

Based on the above discussion and analysis, the share price of Alembic Ltd is likely to touch the level of around Rs.225-250 in 2030

Alembic Ltd Share Price Target 2035:

Based on the above discussion and analysis, the share price of Alembic Ltd is likely to touch the level of around Rs.500-550 in 2035

Alembic Ltd Share Price Target 2040:

Based on the above discussion and analysis, the share price of Alembic Ltd is likely to touch the level of around Rs.1100-1200 in 2040

Disclaimer: Investment in Capital Market/Share Prices are subject to market fluctuations and are dependent on several factors. These predictions are based on the current market conditions and the future market expectations. Investors are advised to take into consideration all these factors before making any investment in Capital Market. This article should not be treated as Investment advisory and is for general Guidance & Educational purpose only. We keep revising our share price targets based on the latest information available with us. Please keep visiting our website regularly to keep yourself updated. MoneyInsight does not offer investment advice and does not encourage any action based on its content.

Read Also: